Industry

CRO Alliance Pharma’s Executive Team Grows by Four, Supporting Bioanalytical and CMC Testing Expansions

MALVERN, Pa.–(BUSINESS WIRE)–Alliance Pharma (Alliance), a global leader in bioanalytical, DMPK and CMC testing services in the pharmaceutical and biopharmaceutical industry, has grown their leadership team by four, bringing on board a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued … [Read more…]

AbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the Clinic

VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced it has launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada. The 380,000-square-foot tech campus will include state-of-the-art lab and office spaces to support AbCellera’s capabilities in bringing new antibody-based medicines from target to the clinic. The … [Read more…]

BioXpedia A/S and BioSkryb Genomics Announce European Partnership to Provide Groundbreaking, Single-Cell, Multiomic Analysis for Novel Target Identification and Therapeutic Development

This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in targeted disease management. DURHAM, N.C. & AARHUS, Denmark–(BUSINESS WIRE)–#CRISPR—BioSkryb Genomics, a pioneer in developing scientifically advanced single-cell … [Read more…]

More than 1.5 Billion Women Worldwide Lack Essential Health Screenings

Hologic Global Women’s Health Index finds widespread barriers to preventive care and a growing gap in women’s well-being between high- and low-income countries MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #Gallup–More than 1.5 billion women worldwide lack screenings for cancer, heart disease, diabetes or sexually transmitted diseases/infections – even though these conditions together affect billions of women. The finding … [Read more…]

Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck

NERVIANO, Italy–(BUSINESS WIRE)–Nerviano Medical Sciences S.r.l. (NMS), a member of the NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, announced today the signing of a collaboration agreement with licensing option with Merck Healthcare KGaA (Merck), for the next-generation highly selective and brain penetrant PARP1 inhibitor NMS-293. … [Read more…]

Merck KGaA, Darmstadt, Germany Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

Not intended for UK- or Canada-based media NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the treatment of patients with BRCA-mutated tumors and in combination with temozolomide in recurrent glioblastoma Next generation PARP1 selective inhibitors could fill a significant unmet patient need … [Read more…]

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

Not intended for US-, Canada- or UK-based media NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the treatment of patients with BRCA-mutated tumors and in combination with temozolomide in recurrent glioblastoma Next generation PARP1 selective inhibitors could fill a significant unmet patient … [Read more…]

CORRECTING and REPLACING Yuluka Health’s Animal Product Line Is Connecting Its Holistic Wellness Products with Top Equestrians

MIAMI–(BUSINESS WIRE)–Please replace the release dated September 20, 2022, with the following corrected version due to multiple revisions. The updated release reads: YULUKA HEALTH’S ANIMAL PRODUCT LINE IS CONNECTING ITS HOLISTIC WELLNESS PRODUCTS WITH TOP EQUESTRIANS Yuluka Health Inc. is a global company with a strong social conscience that prioritizes the health and well-being of … [Read more…]

S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator™ 100 System with Proteigene in France

LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in France. … [Read more…]

Carmot Therapeutics Announces Significant Leadership Team Expansion with Anne Phillips, MD, FRCPC Previously SVP Novo Nordisk, Joining the Board of Directors and Heather Turner, J.D. Joining as COO

BERKELEY, Calif.–(BUSINESS WIRE)–Carmot Therapeutics, Inc. (Berkeley, CA), a clinical-stage biotechnology company applying its proprietary drug discovery platform, Chemotype Evolution, to discover and develop disease-modifying therapies in metabolic disease and cancer, announced today an expansion of its Board of Directors and executive leadership team. Anne Phillips, MD, FRCPC joins Carmot’s Board and Heather Turner, J.D., joins … [Read more…]